[DOI] [PMC free article] [PubMed] [Google Scholar] 18.Knezevic M., Gojkovic S., Krezic I., Zizek H., Vranes H., Malekinusic D., Vrdoljak B., Knezevic T., Pavlov K.H., Drmic D., et al
Book a weight-loss call
The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: a post hoc analysis
Wegovy: New clinical trial says this weight-loss medication sheds more pounds Most Americans who want to lose weight dont want to take GLP-1 drugs like Wegovy and Zepbound, new survey says Subscribe to Well Adjusted, our newsletter full of simple strategies to work smarter and live better, from the Fortune Well team
However, other data are necessary to further corroborate this mechanism
Most research on middle ear infections has been conducted in children